- Home
- INSE vs PROK Comparison
INSE vs PROK Comparison
Compare INSE & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSE
- PROK
- Stock Information
- Founded
- INSE N/A
- PROK 2015
- Country
- INSE United States
- PROK United States
- Employees
- INSE 1700
- PROK N/A
- Industry
- INSE Computer Software: Prepackaged Software
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INSE Technology
- PROK Health Care
- Exchange
- INSE Nasdaq
- PROK Nasdaq
- Market Cap
- INSE 263.7M
- PROK 220.6M
- IPO Year
- INSE N/A
- PROK N/A
- Fundamental
- Price
- INSE $10.00
- PROK $1.74
- Analyst Decision
- INSE Buy
- PROK Buy
- Analyst Count
- INSE 3
- PROK 5
- Target Price
- INSE $15.00
- PROK $4.50
- AVG Volume (30 Days)
- INSE 89.7K
- PROK 431.7K
- Earning Date
- INSE 11-07-2024
- PROK 11-12-2024
- Dividend Yield
- INSE N/A
- PROK N/A
- EPS Growth
- INSE N/A
- PROK N/A
- EPS
- INSE N/A
- PROK N/A
- Revenue
- INSE $297,900,000.00
- PROK N/A
- Revenue This Year
- INSE N/A
- PROK N/A
- Revenue Next Year
- INSE $3.93
- PROK N/A
- P/E Ratio
- INSE N/A
- PROK N/A
- Revenue Growth
- INSE N/A
- PROK N/A
- 52 Week Low
- INSE $7.51
- PROK $1.18
- 52 Week High
- INSE $11.00
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- INSE 52.65
- PROK 46.63
- Support Level
- INSE $9.89
- PROK $1.50
- Resistance Level
- INSE $10.34
- PROK $1.81
- Average True Range (ATR)
- INSE 0.39
- PROK 0.20
- MACD
- INSE -0.03
- PROK -0.01
- Stochastic Oscillator
- INSE 23.98
- PROK 32.26
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments namely Gaming; Virtual Sports; Interactive and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.